RecruitingNot Applicable

Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama

United States250 participantsStarted 2021-04-26

Plain-language summary

The purpose of the study is to find out if a self-administered (by the patient) Papanicolaou (Pap) smear is as accurate as a traditional Pap smear administered by a healthcare provider.

Who can participate

Age range21 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female of at least 21 years of age and not over 65 presenting who need routine cervical cancer screening per national guidelines. Exclusion Criteria: * prior history of cervical cancer or a positive Pap smear, have had a total hysterectomy (removal of uterus and cervix), or currently enrolled in any other cancer prevention study.

What they're measuring

Evaluate the self-PAP against the traditional Pap smear procedure

Timeframe: Baseline through 14 days

Trial details

NCT IDNCT04093388

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

John B Waits, MD

2052772379 john.waits@cahabamedicalcare.com

View on ClinicalTrials.gov More Cervical Cancer trials